HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Has Positive Outlook On RFID Initiative, Seeks Supply Chain Efficiency

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble's implementation of a radio frequency identification system may compensate for shortcomings in its supply chain, CEO A.G. Lafley said Oct. 27

You may also be interested in...



RFID Costs Pose Hurdle For OTC Industry, Pfizer Exec Says

The high cost of Radio Frequency Identification technology may preclude its expanded use in the OTC arena even as firms are exploring the technology for use with Rx drugs, according to Tim Marsh, technical manager of global packaging technology for Lubriderm marketer Pfizer

RFID Costs Pose Hurdle For OTC Industry, Pfizer Exec Says

The high cost of Radio Frequency Identification technology may preclude its expanded use in the OTC arena even as firms are exploring the technology for use with Rx drugs, according to Tim Marsh, technical manager of global packaging technology for Lubriderm marketer Pfizer

RFID Implementation Must Ensure Consumer Privacy – FTC’s Beales

Consumer privacy concerns must be addressed by retailers and manufacturers as they implement radio frequency identification technology, Federal Trade Commission Bureau of Consumer Protection Director J. Howard Beales said during an FTC RFID workshop June 21 in Washington, D.C

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011639

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel